Hers Review

In our interactions with Hers, we’ve only ever engaged with customer service representatives, never a core leadership or medical team. However, we can’t help but be impressed at how well the company executes at its massive scale. Their system is clearly built for efficiency, providing fast but rigid support that serves a huge customer base.

The public perception of Hers is a matter of scale. While their review scores aren’t always as high as smaller competitors, you have to consider the sheer volume of them. In the review business, it’s easy to give bias to smaller companies with a “face” behind them, but Hims’ overall feedback is representative of a decent, well-run public company.

The core operational context for Hers is its size and market position as a multi-billion dollar company. This scale is what makes them a good option for some but a poor one for others; they have recently pivoted away from most compounded GLP-1s to partner directly for brand-names like Zepbound and Wegovy, which are often prohibitively expensive without insurance coverage. Note: this is an ever changing environment and there is recent news that Novo Nordisk (Wegovy) has ended their partnership with Hims.

Ultimately, while Hers is a solid option with a wide lineup of weight loss solutions, you won’t find the more personable feel that smaller telehealth companies can offer. The rigidity that allows them to operate at scale is their primary drawback, making them a better fit for a customer who values a well-known brand where they will get a generally consistent experience.